New technologies for the engineering of novel protein therapeutics and the personalization of medicine.
作者信息
Dorner Andrew J, Projan Steven
出版信息
Curr Opin Pharmacol. 2008 Oct;8(5):598-9. doi: 10.1016/j.coph.2008.08.008. Epub 2008 Sep 18.
PMID:18773971
Abstract
摘要
相似文献
1
New technologies for the engineering of novel protein therapeutics and the personalization of medicine.用于新型蛋白质疗法工程设计和医学个性化的新技术。
Curr Opin Pharmacol. 2008 Oct;8(5):598-9. doi: 10.1016/j.coph.2008.08.008. Epub 2008 Sep 18.
2
Immunogenicity of protein therapeutics.蛋白质治疗药物的免疫原性。
Trends Immunol. 2007 Nov;28(11):482-90. doi: 10.1016/j.it.2007.07.011. Epub 2007 Oct 25.
3
Tunable antibodies.可调谐抗体
Nat Biotechnol. 2005 May;23(5):556-7. doi: 10.1038/nbt0505-556.
4
Editorial: biopharmaceutical technologies.社论：生物制药技术
Biotechnol J. 2007 Jun;2(6):647. doi: 10.1002/biot.200790060.
5
Recent developments in engineering and delivery of protein and antibody therapeutics.
Curr Opin Biotechnol. 2011 Dec;22(6):839-42. doi: 10.1016/j.copbio.2011.08.001. Epub 2011 Aug 20.
6
Three decades of human monoclonal antibodies: past, present and future developments.三十年的人源单克隆抗体：过去、现在与未来的发展
Hum Antibodies. 2009;18(1-2):1-10. doi: 10.3233/HAB-2009-0196.
7
Engineered antibody therapeutics.工程化抗体疗法
Adv Drug Deliv Rev. 2006 Aug 7;58(5-6):631-2. doi: 10.1016/j.addr.2006.05.001. Epub 2006 May 20.
8
Antibodies come back from the brink.抗体从边缘状态恢复过来。
Nat Biotechnol. 1998 Nov;16(11):1015-6. doi: 10.1038/3460.
9
Protein engineering: The fate of fingers.蛋白质工程：指状结构的命运
Nature. 2008 Sep 11;455(7210):160-4. doi: 10.1038/455160a.
10
Discovering and improving novel peptide therapeutics.发现并改进新型肽类疗法。
Curr Opin Pharmacol. 2008 Oct;8(5):616-9. doi: 10.1016/j.coph.2008.06.002. Epub 2008 Jul 16.
Zotero 插件